[{"Assets_0_Q3_USD":25492200000.0,"CIK":"875045","Country":"United States","EarningsPerShareBasic_1_Q3_USD":7.17,"EarningsPerShareBasic_3_Q3_USD":16.86,"EarningsPerShareDiluted_1_Q3_USD":7.15,"EarningsPerShareDiluted_3_Q3_USD":16.83,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"32775642095.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":4292300000.0,"NetIncomeLossConverted_1_Q3_USD":1444400000.0,"NetIncomeLossConverted_3_Q3_USD":3483900000.0,"OfficialName":"Biogen Inc. Common Stock","RevenuesConverted_1_Q3_USD":3439000000.0,"RevenuesConverted_3_Q3_USD":9926600000.0,"SP500":"SP500","Sector":"Health Care","StockholdersEquityConverted_0_Q3_USD":13759800000.0,"StockholdersEquity_0_Q3_USD":13766600000.0,"Ticker":"BIIB","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":201900000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":207000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":201400000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":206600000.0,"filed":"20181023","footnote":"nan","form":"10-Q","fp":"Q3","fy":"2018.0","name":"BIOGEN INC.","period":"20180930","qtrs":"0","uom":"USD"}]